ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of GM602 in Patients With Acute Middle Cerebral Artery Ischemic Stroke Within 18 Hours (GMAIS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01221246
Recruitment Status : Completed
First Posted : October 14, 2010
Last Update Posted : February 23, 2018
Sponsor:
Collaborators:
University of California, Los Angeles
Huntington Hospital
Hoag Memorial Hospital Presbyterian
Columbia University
California Pacific Medical Center Research Institute
University Hospital Erlangen
Sarasota Memorial Hospital
University of Louisville
Information provided by (Responsible Party):
Genervon Biopharmaceuticals, LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 7, 2016
  Actual Study Completion Date : July 7, 2016